Epstein-Barr Virus– and Kaposi Sarcoma-Associated Herpesvirus–Related Malignancies in the Setting of Human Immunodeficiency Virus Infection
- 1 April 2015
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 42 (2) , 258-271
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2012
- Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi SarcomaCancer Letters, 2011
- Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United StatesCancer, 2010
- Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus‐associated Kaposi sarcomaCancer, 2010
- Lack of Evidence for Frequent Heterosexual Transmission of Human Herpesvirus 8 in ZimbabweClinical Infectious Diseases, 2009
- Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapyBritish Journal of Cancer, 2008
- Evidence for a Pathogenic Determinant in HIV-1 Nef Involved in B Cell Dysfunction in HIV/AIDSCell Host & Microbe, 2008
- Frequent and Asymptomatic Oropharyngeal Shedding of Human Herpesvirus 8 among Immunocompetent MenThe Journal of Infectious Diseases, 2007
- Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapyBritish Journal of Cancer, 2006
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994